TEXTO / LLAMADA 678-974-8435
Under-eye rejuvenation is a popular aesthetic trend, and Platelet-Derived Growth Factor (PDGF) is a newcomer that’s been getting attention online and in some clinics. At Aviva Plastic Surgery & Aesthetics, we closely follow the science and the regulators. Below is a clear, patient-friendly look at what PDGF is, where it stands with the FDA, and safe, available alternatives we offer today, including nanofat injections and lower blepharoplasty.
PDGF is a biologic growth factor that stimulates cells involved in tissue repair and collagen production. Because the skin beneath the eyes is thin and ages quickly, some clinicians and companies have promoted PDGF as a way to “regenerate” that tissue, improve texture, and restore volume without traditional fillers.
It’s important to be precise: while PDGF products may have FDA clearance for certain wound-healing or surgical applications, using PDGF as an injectable for under-eye rejuvenation is considered an off-label/aesthetic use and has not been broadly FDA-approved for that specific indication.
That distinction matters for safety, the consistency of product formulations, and what clinical evidence is available. We are actively monitoring FDA updates and the peer-reviewed literature as new data and regulatory actions appear.
Research into growth factors and platelet concentrates for facial rejuvenation shows promising signals, such as improved skin quality, collagen stimulation, and better texture. However, high-quality, large trials specifically proving the safety and efficacy of PDGF injections for tear troughs are still limited.
In contrast, regenerative approaches such as nanofat injections have a growing body of literature supporting facial rejuvenation outcomes. Studies and clinical experience show improvements in fine lines, skin quality, and under-eye appearance when performed by experienced surgeons.
Nanofat Injections
Lower Blepharoplasty (Lower Eyelid Surgery)
The under-eye area is anatomically delicate. Any injectable or surgical treatment should be performed by clinicians experienced in periorbital anatomy.
Keep in mind that off-label or new biologic therapies may vary in formulation, potency, and technique, and consistent safety data may not yet exist. We only adopt new treatments after reviewing safety, reproducibility, and regulatory developments.
If you’re reading about PDGF online and considering treatment, ask important questions:
If the appearance of tired or hollow under-eyes is bothering you, the best next step is a personalized consultation. We’ll assess your anatomy, discuss realistic outcomes, review risks, and recommend the safest, most effective treatment plan for your goals whether that’s nanofat injections, lower blepharoplasty, or a conservative non-surgical approach.
Book a consultation with our team to get a tailored plan and to hear the latest we’re tracking about PDGF and other emerging options